Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

3.130 +0.040 (+1.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Price and Volume

Volume	3,280,174
Open	3.130
Bid (Size)	3.130 (1,600)
Ask (Size)	3.160 (400)
Prev. Close	3.090
Today's Range	3.010 - 3.165
52wk Range	2.610 - 6.550
Shares Outstanding	191,500,944
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick

September 08, 2026

A look at the three approaches competing to help beta cell replacement survive the immune system

From Biotech Insider

Via GlobeNewswire

Sana Biotechnology to Present at September 2026 Investor Conferences

September 01, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Performance

YTD	-25.3%	-25.3%
1 Month	-17.0%	-17.0%
3 Month	+16.8%	+16.8%
6 Month	-6.8%	-6.8%
1 Year	-7.9%	-7.9%

More News

Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates

August 10, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

July 13, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

July 01, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at June 2026 Investor Conferences

May 27, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

May 15, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 11, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

May 05, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

April 27, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Peraso (NASDAQ: PRSO) Delivers Military Drone IFF Systems, Stock Sets Up for Potential Re-Coil

April 14, 2026

Via AB Newswire

Reloading Alert: PRSO, SANA, ROLR, PMNT – Catalysts Align as Momentum Builds

April 14, 2026

Via AB Newswire

Tuesday's session: gap up and gap down stocks ↗

April 14, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 14, 2026

Via Chartmill

These stocks are moving in today's after hours session ↗

April 13, 2026

Via Chartmill

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

April 13, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

March 13, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

March 03, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at March 2026 Investor Conferences

February 23, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

February 17, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 07, 2026

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

December 08, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at December 2025 Investor Conferences

November 24, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger ↗

November 10, 2025

Via Benzinga

Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates

November 06, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Frequently Asked Questions

Is Sana Biotechnology, Inc. - Common Stock publicly traded?

Yes, Sana Biotechnology, Inc. - Common Stock is publicly traded.

What exchange does Sana Biotechnology, Inc. - Common Stock trade on?

Sana Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sana Biotechnology, Inc. - Common Stock?

The ticker symbol for Sana Biotechnology, Inc. - Common Stock is SANA on the Nasdaq Stock Market

What is the current price of Sana Biotechnology, Inc. - Common Stock?

The current price of Sana Biotechnology, Inc. - Common Stock is 3.130

When was Sana Biotechnology, Inc. - Common Stock last traded?

The last trade of Sana Biotechnology, Inc. - Common Stock was at 09/11/26 04:00 PM ET

What is the market capitalization of Sana Biotechnology, Inc. - Common Stock?

The market capitalization of Sana Biotechnology, Inc. - Common Stock is 599.40M

How many shares of Sana Biotechnology, Inc. - Common Stock are outstanding?

Sana Biotechnology, Inc. - Common Stock has 599M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.